Drug Profile
Inhibin
Latest Information Update: 24 Oct 2021
Price :
$50
*
At a glance
- Originator Ajinomoto; Genentech
- Class Antineoplastics; Antithrombotics; Glycoproteins
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 15 Nov 1994 Discontinued-Preclinical for Cancer (Unknown route)